MYSTERIOUS: 5 - What They Never Told You

Covid vaccine lessons could 'accelerate cancer vaccine' in next 8 years

The founders of coronavirus jab manufacturers BioNTech say developing it gave back to their cancer work

Wales Online · Oct 16, 2022

Vaccines to treat cancer possible by 2030, say BioNTech founders

Uğur Şahin and Özlem Türeci say mRNA Covid vaccine technology could be repurposed to help destroy cancer cells

The Guardian - UK · Oct 16, 2022

Cancer vaccines will be available within 10 years thanks to Covid jabs, scientists say

Ugur Sahin and Ozlem Tureci, the founders of leading coronavirus vaccine makers BioNTech, have had significant “breakthroughs” in cancer research

Daily Mirror · Oct 16, 2022

Check Out What Whales Are Doing With BNTX

Someone with a lot of money to spend has taken a bullish stance on BioNTech (NASDAQ:BNTX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Sep 19, 2022

Brazil approves Pfizer vaccine for children as young as six months

Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night.

Reuters · Sep 17, 2022

EU Regulator Backs Pfizer's BA.4/5-Adapted COVID Booster

The European Medicines Agency (EMA) on Monday recommended a COVID-19 booster designed to combat Omicron offshoots BA.4/5, days after endorsing a pair of boosters tailored to target the older BA.1 variant. The latest recommendation is for a so-called bivalent vaccine developed by Pfizer and BioNTech, which targets BA.4/5 as well…

Asharq Al-Awsat · Sep 12, 2022

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

Benzinga · Sep 9, 2022

Second Covid booster jab approved in UK ahead of winter vaccine programme

It’s the second jab aimed at both the original and Omicron strains of the virus, to be approved in the UK

Evening Standard · Sep 3, 2022

FDA greenlights new COVID-19 booster despite limited data - Roll Call

The Food and Drug Administration granted emergency authorization to Pfizer and Moderna for updated COVID-19 booster shots.

Roll Call · Aug 31, 2022

Moderna's COVID vaccine lawsuit looks ahead to future markets

Moderna's COVID vaccine lawsuit looks beyond the pandemic to future markets

Axios · Aug 29, 2022